Alerts will be sent to your verified email
Verify Email
RPGLIFE
|
RPG Life Sciences
|
Suven Life Sciences
|
Aarti Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Domestic Sales Growth - YoY
|
-11.18 % | n/a | n/a |
|
R&D as a % of Total Sales
|
1.11 % | 2132.75 % | 1.93 % |
|
Financials
|
|||
|
5 yr Average ROE
|
23.71 % | -82.05 % | 18.02 % |
|
5yr average Equity Multiplier
|
1.34 | 1.55 | 1.97 |
|
5yr Average Asset Turnover Ratio
|
1.18 | 0.05 | 1.09 |
|
5yr Avg Net Profit Margin
|
15.65 % | -1150.51 % | 8.24 % |
|
Price to Book
|
6.84 | 13.66 | 2.48 |
|
P/E
|
17.58 | 0.0 | 18.26 |
|
5yr Avg Cash Conversion Cycle
|
-53.67 Days | 97.84 Days | 79.88 Days |
|
Inventory Days
|
61.98 Days | 10.88 Days | 69.48 Days |
|
Days Receivable
|
35.4 Days | 71.91 Days | 111.3 Days |
|
Days Payable
|
143.49 Days | 3.38 Days | 97.75 Days |
|
5yr Average Interest Coverage Ratio
|
30.59 | -373.47 | 9.61 |
|
5yr Avg ROCE
|
28.37 % | -82.34 % | 21.16 % |
|
5yr Avg Operating Profit Margin
|
20.94 % | -1227.3 % | 14.01 % |
|
5 yr average Debt to Equity
|
0.0 | 0.0 | 0.46 |
|
5yr CAGR Net Profit
|
35.58 % | 17.38 % | -9.72 % |
|
5yr Average Return on Assets
|
17.85 % | -54.63 % | 9.12 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.95 % | 67.36 % | 54.72 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.34 % | 2.38 % | -5.05 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.2 % | 2.07 % | 6.73 % |
|
RPG Life Sciences
|
Suven Life Sciences
|
Aarti Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
Therapeutic Area Break-Up
|